Udwartana followed by Virechana in Dyslipidemia, a Clinical Study

A randomized open labelled comparative clinical study to evaluate the efficacy of Virechana with and without Snehapurva Rukshana in the management of Dyslipidemia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023890

Enrollment

Registered

2020-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

Intervention1: Virechana with Snehapurva Rukshana in Dyslipidemia: Deepana - Pachana with trikatu choorna 1tsf 3 times a day with half glass warm water till nirama lakshana are seen. Rukshana with udw

Eligibility

Inclusion criteria

Inclusion criteria: subjects diagnosed with dyslipidemia with any of the serum lipid levels, S. Cholesterol - 200-500mg/dl S. Triglycerides - 150-400mg/dl HDL - LDL - 130-400mg/dl Subjects fit for Snehapana, Swedana, Udwartana and Virechana VLDL - 40-200mg/dl

Exclusion criteria

Exclusion criteria: Subjects unfit for snehapana, swedana, udwartana and virechana. Subjects with type 1 diabetes, uncontrolled diabetes mellitus, uncontrolled hypertension, cardiovascular diseases Dyslipidemia due to endocrine or renal pathologies Dyslipidemia due to drugs e.g. glucocorticoids etc Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Changes in Serum Lipid levelsTimepoint: Before treatment, After treatment - next day of Virechana, On follow up - after 15 days of Samsarjana krama	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Reeny Ravina Dias

Sri Sri College of Ayurvedic Science and Research, Bengaluru

drganeshputtur@gmail.com9448176059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026